Vimarsana
Biggest News Aggregation in the World

Page 3 - Nasdaq Blu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Blu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Blu Today - Breaking & Trending Today

BELLUS Health (NASDAQ:BLU) Sees Strong Trading Volume - Vimarsana News

BELLUS Health (NASDAQ:BLU) Sees Strong Trading Volume

BELLUS Health Inc. (NASDAQ:BLU – Get Rating) shares saw strong trading volume on Wednesday . 323,183 shares were traded during mid-day trading, a decline of 51% from the previous session’s volume of 664,591 shares.The stock last traded at $6.90 and had previously closed at $6.95. Analyst Upgrades and Downgrades A number of equities analysts recently […]

BELLUS Health (NASDAQ:BLU) Shares Up 6.3% - Vimarsana News

BELLUS Health (NASDAQ:BLU) Shares Up 6.3%

Shares of BELLUS Health Inc. (NASDAQ:BLU – Get Rating) shot up 6.3% on Thursday . The company traded as high as $6.89 and last traded at $6.87. 387,856 shares changed hands during trading, a decline of 41% from the average session volume of 662,235 shares. The stock had previously closed at $6.46. Analyst Upgrades and […]

Source: wkrb13.com
BELLUS Health's (BLU) Buy Rating Reaffirmed at HC Wainwright - Vimarsana News

BELLUS Health's (BLU) Buy Rating Reaffirmed at HC Wainwright

HC Wainwright reiterated their buy rating on shares of BELLUS Health (NASDAQ:BLU – Get Rating) in a research report sent to investors on Wednesday, Benzinga reports. They currently have a $20.00 target price on the stock. HC Wainwright also issued estimates for BELLUS Health’s Q1 2023 earnings at ($0.20) EPS, Q2 2023 earnings at ($0.21) […]

Source: wkrb13.com
FY2027 EPS Estimates for BELLUS Health Inc. Lifted by Analyst (NASDAQ:BLU) - Vimarsana News

FY2027 EPS Estimates for BELLUS Health Inc. Lifted by Analyst (NASDAQ:BLU)

BELLUS Health Inc. (NASDAQ:BLU – Get Rating) – Analysts at Jefferies Financial Group upped their FY2027 EPS estimates for BELLUS Health in a research report issued to clients and investors on Tuesday, March 21st. Jefferies Financial Group analyst S. Jeong now anticipates that the company will post earnings per share of $4.17 for the year, […]

BELLUS Health's (BLU) Buy Rating Reiterated at HC Wainwright - Vimarsana News

BELLUS Health's (BLU) Buy Rating Reiterated at HC Wainwright

HC Wainwright reissued their buy rating on shares of BELLUS Health (NASDAQ:BLU – Get Rating) in a research note published on Wednesday, Benzinga reports. They currently have a $20.00 target price on the stock. HC Wainwright also issued estimates for BELLUS Health’s Q1 2023 earnings at ($0.20) EPS, Q2 2023 earnings at ($0.21) EPS, Q3 […]